All In Biotech

Drug Trial Radar · NCT00622908

Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis

Last checked: Nov 20, 2026Latest source record: Mar 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 270 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

270

Actual

Start

Dec 2004

Primary completion

Jun 2005

Study completion Jun 2005

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Feb 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 1 year
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the clinical and microbial efficacy of ISV-403 administered three times a day (TID) for 5 days compared to vehicle three times a day for 5 days in the treatment of bacterial conjunctivitis

Conditions

  • Bacterial Conjunctivitis

Interventions

  • ISV-403Drug

    0.6% TID, 5 days

  • VehicleDrug

    Vehicle of ISV-403 TID, 5 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Resolution of Baseline Bacterial Conjunctivitis (Day 8 or 9)Time frame: Visit 3 - day 8 or 9
  2. Eradication of Baseline Pathogens (Day 8 or 9)Time frame: Visit 3 - Day 8 or day 9

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.